187 related articles for article (PubMed ID: 30683911)
1. Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma.
Mahadevan KK; Arora KS; Amzallag A; Williams E; Kulkarni AS; Fernandez-Del Castillo C; Lillemoe KD; Bardeesy N; Hong TS; Ferrone CR; Ting DT; Deshpande V
Mod Pathol; 2019 Jun; 32(6):844-854. PubMed ID: 30683911
[TBL] [Abstract][Full Text] [Related]
2. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
Handra-Luca A; Hammel P; Sauvanet A; Ruszniewski P; Couvelard A
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):294-302. PubMed ID: 22581056
[TBL] [Abstract][Full Text] [Related]
3. Well differentiation and intact Smad4 expression are specific features of groove pancreatic ductal adenocarcinomas.
Izumi S; Nakamura S; Mano S; Akaki S
Pancreas; 2015 Apr; 44(3):394-400. PubMed ID: 25426619
[TBL] [Abstract][Full Text] [Related]
4. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
Liang C; Shi S; Qin Y; Meng Q; Hua J; Hu Q; Ji S; Zhang B; Xu J; Yu XJ
Gut; 2020 May; 69(5):888-900. PubMed ID: 31611300
[TBL] [Abstract][Full Text] [Related]
5. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
[TBL] [Abstract][Full Text] [Related]
6. Ductal adenocarcinoma of the pancreas usually retained SMAD4 and p53 protein status as well as expression of epithelial-to-mesenchymal transition markers and cell cycle regulators at the stage of liver metastasis.
Liszka L
Pol J Pathol; 2014 Jun; 65(2):100-12. PubMed ID: 25119169
[TBL] [Abstract][Full Text] [Related]
7. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
[TBL] [Abstract][Full Text] [Related]
8. SMAD4 expression predicts local spread and treatment failure in resected pancreatic cancer.
Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2015 May; 44(4):660-4. PubMed ID: 25760429
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
10. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
11. Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma.
Yamada M; Hirabayashi K; Kawanishi A; Hadano A; Takanashi Y; Izumi H; Kawaguchi Y; Mine T; Nakamura N; Nakagohri T
Surg Today; 2018 May; 48(5):510-516. PubMed ID: 29256146
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
[TBL] [Abstract][Full Text] [Related]
13. SMAD4-Expressing Pancreatic Ductal Adenocarcinomas Have Better Response to Neoadjuvant Therapy and Significantly Lower Lymph Node Metastasis Rates.
Kassardjian A; Wang HL
Pancreas; 2020 Oct; 49(9):1153-1160. PubMed ID: 32897998
[TBL] [Abstract][Full Text] [Related]
14. LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4.
Li Z; Ma Z; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Chen Y; Han M; Wu Z; Huang S; Zhou Q; Hou B; Zhang C
Biol Direct; 2024 Mar; 19(1):24. PubMed ID: 38504385
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
16. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
17. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
18. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition.
Xiong C; Zhu Y; Xue M; Jiang Y; Zhong Y; Jiang L; Shi M; Chen H
Aging (Albany NY); 2021 Jan; 13(3):3386-3404. PubMed ID: 33428605
[TBL] [Abstract][Full Text] [Related]
20. Aquaporins in pancreatic ductal adenocarcinoma.
Bruun-Sørensen AS; Edamana S; Login FH; Borgquist S; Nejsum LN
APMIS; 2021 Dec; 129(12):700-705. PubMed ID: 34582595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
